This Government Contract opportunity from Department Of Defense was posted on August 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Veterinary Pharmaceutical Manufacturing & Supply
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This subcontract involves the production and supply of Maropitant Citrate 160mg tablets for the Department of Defense, specifically managed by the Medical Supply Chain Pharm FSA. The manufacturer must ensure all products are provided in blister packs that adhere to FDA regulations, current Good Manufacturing Practices, and specific military packaging standards. The project falls under NAICS code 325412 and is scheduled for performance at APO 09227-0000. Interested parties must respond by August 18, 2026, following the posting date of August 12, 2026.
General Info
Agency
NAICS
Place of Performance
APO, AE, 09227-0000, USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-4624.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
MAROPITANT CITRATE
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS